Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00109681
What this trial is testing

Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Actelion 50
Not applicableUnknownNCT04179058
What this trial is testing

Interstitial Pneumonia With Autoimmune Features: Evaluation of Connective Tissue Disease Incidence During Follow-up

Who this might be right for
Idiopathic Interstitial Pneumonia
Central Hospital, Nancy, France 300
Early research (Phase 1)Study completedNCT07588646
What this trial is testing

Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Sunshine Lake Pharma Co., Ltd. 33
Testing effectiveness (Phase 2)Study completedNCT01265888
What this trial is testing

Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.

Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary Fibrosis
Geno LLC 31
Early research (Phase 1)Study completedNCT02648048
What this trial is testing

Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 21
Not applicableNot Yet RecruitingNCT07723638
What this trial is testing

New Diagnostic Approaches in the Management of Inflammatory Lung Diseases

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)Idiopathic Pulmonary Fibrosis
Fondazione Don Carlo Gnocchi ETS 200
Not applicableStudy completedNCT03222648
What this trial is testing

Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis

Who this might be right for
BreathlessnessQuality of LifeIdiopathic Pulmonary Fibrosis
University Hospital Southampton NHS Foundation Trust 17
Not applicableStudy completedNCT02600689
What this trial is testing

Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Alabama at Birmingham 20
Early research (Phase 1)Study completedNCT04931147
What this trial is testing

A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

Who this might be right for
FibrosisInflammationIdiopathic Pulmonary Fibrosis+3 more
Redx Pharma Ltd 90
Large-scale testing (Phase 3)Study completedNCT00639496
What this trial is testing

Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Pulmonary Fibrosis
Zambon SpA 184
Not applicableActive Not RecruitingNCT05313672
What this trial is testing

Inspiratory Effort and Respiratory Mechanics in Spontaneously Breathing Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Matched Control Study

Who this might be right for
Idiopathic Pulmonary Fibrosis
Roberto Tonelli 20
Early research (Phase 1)Study completedNCT05468502
What this trial is testing

Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Shanghai Life Science & Technology 17
Large-scale testing (Phase 3)Study completedNCT00287716
What this trial is testing

Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Genentech, Inc. 435
Large-scale testing (Phase 3)Ended earlyNCT00076635
What this trial is testing

An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary FibrosisLung Disease
InterMune 91
Large-scale testing (Phase 3)UnknownNCT00203697
What this trial is testing

Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of California, Los Angeles
Testing effectiveness (Phase 2)Looking for participantsNCT07284459
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Contineum Therapeutics 324
Not applicableStudy completedNCT02699879
What this trial is testing

Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 1,009
Not applicableStudy completedNCT01718990
What this trial is testing

Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
University of California, San Francisco 110
Large-scale testing (Phase 3)Study completedNCT05255991
What this trial is testing

Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung Disease
United Therapeutics 597
Testing effectiveness (Phase 2)Study completedNCT00052052
What this trial is testing

An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Lung DiseasePulmonary Fibrosis
InterMune 210
Next Page